|
Sections
Agriculture
Applied sciences
Arts
Belief
Business
Chronology
Culture
Education
Environment
Geography
Health
History
Humanities
Language
Law
Life
Mathematics
Nature
People
Politics
Science
Society
Technology
|
 TATA Binding Protein http://www.garlandscience.com/product/isbn/9780815341055 The TATA-binding protein is a subunit of RNA polymerase II that initiates mRNA transcription. This v... |  DNA Replication Cartoon Our second cartoon made for our AP Biology class. Comments would be appreciated! We realize that some of this is hard to understand, so here is the script of... |  "Biochemistry", Structural Motifs in DNA-Binding Regulatory Proteins |  Single-Stranded DNA-binding protein (SSB) complex with DNA This is a 100 ns molecular dynamics simulation of Single-Stranded DNA-binding protein (SSB) in complex with a poly-dC 70mer of DNA. MD engine: NAMD2.8. Image... |  identifying a protein binding sites on DNA molecule identifying a protein binding sites on DNA molecule Proteins interact with DNA through electrostatic interactions (salt bridges), dipolar interactions (hydro... |  DNA Replication Paul Andersen explains how DNA replication ensures that each cell formed during the cell cycle has an exact copy of the DNA. He describes the Meselson-Stahl ... |  TATA/Binding Protein DNA Complex TATA binding protein is an initiation factor. Here is the crystal structure of the DNA protein complex. |  DNA Raplication BIO 22 LYRICS: Lets see here now, where do we begin? Lets start at the beginning - the replication origin. The initiator protein Is simply bound to it Its not too d... |  Gene Regulation I This course is part of a series taught by Kevin Ahern at Oregon State University on General Biochemistry. For more information about online courses go to htt... |  DNase footprinting For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html A DNa... |
| |
MarketWatch (press release)
Mon, 20 May 2013 04:01:21 -0700
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP ...
|  OneMedPlace (blog) |
OneMedPlace (blog)
Thu, 16 May 2013 13:26:22 -0700
DNA-binding proteins are critical to regulation, a fundamental paradigm for pharmaceutical development. Thus, it is becoming increasingly important to precisely understand how these systems function. In ChIP, cells are initially treated with formaldehyde.
| | |
PR Newswire (press release)
Thu, 09 May 2013 13:07:26 -0700
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. The Company has ongoing Phase 2 clinical trials to evaluate the safety and efficacy of a novel ZFP ...
| | |
Wall Street Journal (press release)
Wed, 01 May 2013 13:16:37 -0700
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP ...
| | |
Wall Street Journal (press release)
Wed, 24 Apr 2013 15:20:00 -0700
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. The Company has ongoing Phase 2 clinical trials to evaluate the safety and efficacy of a novel ZFP ...
| | |
Wall Street Journal (press release)
Wed, 15 May 2013 07:08:28 -0700
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP ...
| | |
Medical News Today
Wed, 01 May 2013 04:06:39 -0700
"These observations show that new families of sequence-specific DNA-binding proteins may be restricted to small clades and suggest that current annotations -- which rely on deep conservation -- underestimate the fraction of genes coding for ...
| | |
Motley Fool
Thu, 09 May 2013 09:31:39 -0700
What: Shares of Sangamo Biosciences (NASDAQ: SGMO ) , a clinical stage biopharmaceutical company focused on developing zinc finger DNA-binding proteins, rose as much as 11% after the company reported its first-quarter results. So what: Although ...
|
Oops, we seem to be having trouble contacting Twitter
|
|
You can talk about DNA-binding proteins with people all over the world in our discussions.
|
